INVESTORS
Investors Investors
<< Back
Feb 7, 2003

Hill International Selected by Endo Pharmaceuticals as Construction Manager for New R&D Facility

Hill International Selected by Endo Pharmaceuticals as Construction Manager for New R&D Facility
Marlton, NJ -- Hill International, Inc., the worldwide construction consulting firm, has announced that Endo Pharmaceuticals Inc., a market leader in pain management, has selected Hill to provide construction management services during the design and construction of a new research-and-development facility in Westbury, Long Island, New York. This 24,000-sq.-ft. facility will contain analytical and formulation laboratories, office space, conference facilities and a completely new mechanical support system.

Hill’s services will include design oversight, equipment procurement, cost estimating, project scheduling, establishment and maintenance of project controls, and day-to-day construction supervision.

“Hill appreciates the confidence and trust that Endo has placed in us,” said Vincent O. Manuele, Senior Vice President of Hill. “We have extensive experience and we are looking forward to helping Endo successfully complete this important project,” Manuele added.

Endo Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain. Endo Pharmaceuticals Inc. is a wholly owned subsidiary of Endo Pharmaceuticals Holdings Inc.

Hill International provides project management services and construction claims consulting through 20 offices worldwide. Engineering News-Record magazine recently ranked Hill as the 14th largest construction management firm in the United States. For more information on Hill, please visit our website at www.hillintl.com.